⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18515739 | 1.00 | — | — | |
| SCHEMBL374340 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL29288498 | 0.97 | — | — | |
| SCHEMBL167052 | 0.78 | ALDH1A1 (0.37) | — | |
| SCHEMBL33774 | 0.78 | TSHR (0.41) | — | |
| SCHEMBL28069237 | 0.78 | TSHR (0.41) | — | |
| SCHEMBL30262989 | 0.78 | TSHR (0.41) | — | |
| SCHEMBL2356011 | 0.77 | — | — | |
| SCHEMBL1701814 | 0.75 | — | — | |
| SCHEMBL7050445 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000040242-A2 | PREPARATION OF A COMPOSITION AGAINST HEPATITIS B-, HI-, PARAMYXO- AND ORTHOMYXOVIRUSES | AXXIMA PHARMACEUTICALS AG (DE) | 2000-07-13 | — | — | WO | claimed |
| US-5955100-A | TREATMENT OF MALIGNANT TUMORS, INFLAMMATORY DISEASES, OR AUTOIMMUNE DISEASES | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1999-09-21 | — | — | US | claimed |
| JP-7277976-A | — | — | None | — | — | JP | disclosed |
| CN-105820062-A | N-(1-oxo-4-hydroxy-2-butenyl)aminoacetamide compound and preparation method and application thereof | 哈尔滨三联药业股份有限公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-101573326-B | Process for production of betaine | MITSUBISHI RAYON CO | 2013-05-01 | — | — | CN | disclosed |
| US-8334132-B2 | Process for production of a betaine such as carnitine | MITSUBISHI RAYON CO., LTD. (JP) | 2012-12-18 | — | — | US | disclosed |
| US-7838006-B2 | Viral vaccine composition, process and methods of use | IMMUNITOR USA INC. (US) | 2010-11-23 | — | — | US | disclosed |
| US-20090325246-A1 | PROCESS FOR PRODUCTION OF BETAINE | MITSUBISHI RAYON CO., LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| CN-101573326-A | Process for production of betaine | MITSUBISHI RAYON CO (JP) | 2009-11-04 | — | — | CN | disclosed |
| US-20090226489-A1 | VIRAL VACCINE COMPOSITION, PROCESS AND METHODS OF USE | IMMUNITOR USA INC. (US) | 2009-09-10 | — | — | US | disclosed |
| EP-2096103-A1 | PROCESS FOR PRODUCTION OF BETAINE | Mitsubishi Rayon Co. Ltd. (JP) | 2009-09-02 | — | — | EP | disclosed |
| US-20030092145-A1 | Viral vaccine composition, process, and methods of use | IMMUNITOR USA INC. | 2003-05-15 | — | — | US | disclosed |
| WO-2001054717-A1 | VACCINE COMPOSITION, PROCESS AND METHODS | JIRA VIC (US) | 2001-08-02 | — | — | WO | disclosed |
| US-6146658-A | ADMINISTERING A GLYCOSYL-SPACER-DRUG COMPOUND WHERE THE GLYCOSYL IS A SACCHARIDE WHICH CAN BE ENZYMATICALLY CLEAVED; DRUG IS ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE OR ANTITUMOR AGENT WHICH HYDROXYL OR AMINO GROUP; SELF-ELIMINATING SPACER | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-11-14 | — | — | US | disclosed |
| US-6020315-A | Preparation having increased in vivo tolerability | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-02-01 | — | — | US | disclosed |
| US-5955100-A | TREATMENT OF MALIGNANT TUMORS, INFLAMMATORY DISEASES, OR AUTOIMMUNE DISEASES | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1999-09-21 | — | — | US | disclosed |
| JP-H07277976-A | METHOD FOR TREATING HYPERPROLIFERATIVE VASCULAR DISEASE | HOECHST AG | 1995-10-24 | — | — | JP | disclosed |
| WO-1994024095-A1 | IMMUNOSUPPRESSIVE AGENTS | ABBOTT LABORATORIES (US) | 1994-10-27 | — | — | WO | disclosed |